In the United States, doctors often prescribe aspirin to people between the ages of 50 and 70 every day. Even if you have never taken aspirin, you can prevent heart attacks and strokes.
In Europe, the cardiologist does this only after the first heart condition.
Aspirin fluidizes blood and prevents the formation of clots in the arteries. However, too minute blood can cause bleeding. Therefore the dilemma: What kind of patients benefit from the benefits of reducing cardiovascular risk than the risk of bleeding?
There are a number of studies that have already shown that people who have had a stroke or heart attack tend to take aspirin. These people have a definite risk of a second accident and aspirin helps prevent it.
New research Journal of the American Medical Association (JAMA), Provides a broader view of patients who have not yet had cardiovascular disease.
But it does not really solve the controversy. On the other hand, aspirin reduces the risk of heart attack and stroke in people without history. However, on the other hand, there is an increased risk of severe bleeding, especially in the brain, stomach and intestines.
Aspirin does not affect mortality in any way.
"The low effectiveness of aspirin to prevent stroke and heart attack in healthy people is contrary to the increased risk of bleeding.""Says Jane Armitage, a professor of epidemiology at the University of Oxford.
As a conclusion, Doctors should refer to aspirin on a case by case basis for other risks to the patient.I write a comment to cardiologist Michael Gaziano.
For example, stopping smoking or lowering cholesterol levels is another way to reduce cardiovascular risk.
This new study was meta-analytical and the two authors of King's College London studied 13 most important clinical trials on this subject from 1988 to 2018 and concluded based on all these tests.
Using this method, you can eliminate the uncertainty associated with each study and identify more general effects based on the 164,000 people who participated in the total trial.
Surprisingly, research shows that aspirin does not find a link between aspirin and a reduction in the incidence of cancer, as more studies suggest that aspirin reduces the risk of certain cancers, particularly colorectal cancer.
The US Preventive Services Task Force, an organization that publish recommendations on public health, advocates the daily intake of aspirin from people aged 50 to 69 starting in 2016. Among other things, Please.